Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocrevus
Pharma
UPDATED: Roche Q1 earnings see hits and misses across key products
The surging Swiss franc caused Roche's Q1 sales to fall slightly short of Wall Street expectations with a “mix of beats and misses” across key drugs.
Angus Liu
Apr 24, 2026 1:55pm
Zenas gains MS hopeful in $2B deal with China's InnoCare
Oct 8, 2025 11:50am
What's on neurologists' minds? Not drug names, survey shows
Jul 18, 2025 10:10am
Roche's high-dose version of Ocrevus flunks phase 3 trial
Apr 2, 2025 3:26pm
MS meds send CNS market toward strongest growth in years
Mar 26, 2025 10:48am
Roche's Vabysmo will rise above Eylea biosim threat, exec says
Oct 23, 2024 11:24am
